Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) Return on Sales: 2021-2025

Historic Return on Sales for iSpecimen (ISPC) over the last 5 years, with Sep 2025 value amounting to -3.66%.

  • iSpecimen's Return on Sales fell 273.00% to -3.66% in Q3 2025 from the same period last year, while for Sep 2025 it was -3.66%, marking a year-over-year decrease of 273.00%. This contributed to the annual value of -1.38% for FY2024, which is 29.00% down from last year.
  • As of Q3 2025, iSpecimen's Return on Sales stood at -3.66%, which was down 93.87% from -1.89% recorded in Q2 2025.
  • iSpecimen's 5-year Return on Sales high stood at -0.64% for Q1 2021, and its period low was -3.66% during Q3 2025.
  • Its 3-year average for Return on Sales is -1.42%, with a median of -1.10% in 2023.
  • Its Return on Sales has fluctuated over the past 5 years, first rose by 14bps in 2024, then slumped by 273bps in 2025.
  • Quarterly analysis of 5 years shows iSpecimen's Return on Sales stood at -0.84% in 2021, then fell by 15bps to -0.99% in 2022, then declined by 11bps to -1.09% in 2023, then declined by 29bps to -1.38% in 2024, then tumbled by 273bps to -3.66% in 2025.
  • Its Return on Sales was -3.66% in Q3 2025, compared to -1.89% in Q2 2025 and -1.43% in Q1 2025.